Lv01
0 积分 2025-06-24 加入
ILD with Datopotamab Deruxtecan combinations: A warning signal we should not ignore
3小时前
求助中
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
3小时前
已完结
Upregulation of Trop-2 quantitatively stimulates human cancer growth
4小时前
已完结
Mapping the patent landscape of TROP2-targeted biologics through deep learning
8天前
已完结
The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target
8天前
已完结
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
22天前
已完结
Preclinical characterization and phase 1 results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumors
29天前
已完结
FDA approves TROP2-targeted antibody–drug conjugate for breast cancer
1个月前
已完结
Improved biodistribution and antitumor effects of a Nectin4 and Trop2 bispecific fatty acid-modified nanobody conjugate
1个月前
已完结
A bispecific nanobody-drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancer
3个月前
已完结
皖公网安备34019202002308
